Big Data gegen Lieferengpässe: BfArM fordert mehr Transparenz von der Pharmaindustrie.
- Published in:
- GesR: Gesundheitsrecht, 2021, v. 20, n. 12, p. r92, doi. 10.9785/gesr-2021-201202
- Publication type:
- Article
Works matching DE "BUNDESINSTITUT fur Arzneimittel und Medizinprodukte (Germany)"
Results: 12
1
2
Klarstellungen und Änderungen gem. § 295 Abs. 1 S. 8 und § 301 Abs. 2 S. 6 SGB V.
- Published in:
- GesR: Gesundheitsrecht, 2021, v. 20, n. 11, p. r84, doi. 10.9785/gesr-2021-201103
- Publication type:
- Article
3
Aktuelles. BfArM.
- Published in:
- 2021
- Publication type:
- Book Review
4
Liste der verfügbaren Antigentests.
- Published in:
- GesR: Gesundheitsrecht, 2021, v. 20, n. 3, p. r20, doi. 10.9785/gesr-2021-200302
- Publication type:
- Article
5
Beirat zu Liefer- und Versorgungsengpässen.
- Published in:
- GesR: Gesundheitsrecht, 2020, v. 19, n. 9, p. r68, doi. 10.9785/gesr-2020-190903
- Publication type:
- Article
6
Brüche der Seitenarme bei Intrauterinpessaren (IUP).
- Published in:
- GesR: Gesundheitsrecht, 2020, v. 19, n. 1, p. R6
- Publication type:
- Article
7
BfArM.
- Published in:
- GesR: Gesundheitsrecht, 2019, v. 18, n. 9, p. r68, doi. 10.9785/gesr-2019-180903
- Publication type:
- Article
8
Aktuelles. BfArM.
- Published in:
- GesR: Gesundheitsrecht, 2018, v. 17, n. 9, p. r68, doi. 10.9785/gesr-2018-170904
- Publication type:
- Article
9
GesRaktuell.
- Published in:
- GesR: Gesundheitsrecht, 2016, v. 15, n. 9, p. v, doi. 10.9785/gesr-2016-0902
- Publication type:
- Article
10
The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0158354
- By:
- Publication type:
- Article
11
Prescriptions of Cannabinoid Drugs, 2019-2022.
- Published in:
- Deutsches Ärzteblatt International, 2023, v. 120, n. 11, p. 186, doi. 10.3238/arztebl.m2022.0389
- By:
- Publication type:
- Article
12
The Subjective Understanding of Guideline Recommendations and of the Risks of the Side Effects of Medication.
- Published in:
- 2013
- By:
- Publication type:
- Editorial